News
The Power of Informed Advocacy: A Q&A With Healthcare Futurist and Caregiver Jamie Metzl
Jamie Metzl is a writer and technology/health care futurist who regularly speaks to the medical industry on the future of health care. When Jamie’s father,
NETRF Awards 13 Research Grants to Accelerate Neuroendocrine Cancer Treatments and Cures
The Neuroendocrine Tumor Research Foundation (NETRF) today announced its latest round of neuroendocrine cancer research grant recipients. The thirteen investigators receiving awards are pursuing innovative,
A Mitzvah of Love, Memory, and Purpose
In November 2025, Drew Greenberg marked his Bar Mitzvah in a way that moved everyone who heard his story. At just 13 years old, Drew
With Gratitude and Momentum: Updates to NETRF’s BOSA Leadership
The Neuroendocrine Tumor Research Foundation (NETRF) is pleased to share an important leadership transition within our Board of Scientific Advisors (BOSA), a group of distinguished
NETRF Clinical Trial Roundup: January 2026
Highlights from recent clinical trial developments in neuroendocrine cancer Neuroendocrine cancer research continues to evolve, with a growing number of clinical trials exploring bold, highly
New Blood Test May Help Guide Neuroendocrine Cancer Therapy
By Anna C. Greene, PhD, NETRF Chief Scientific Officer One of the most exciting developments in neuroendocrine cancer treatment in recent years has been the
What New Data Tells Us About the Neuroendocrine Cancer Diagnostic Journey
By Anna C. Greene, PhD, NETRF Chief Scientific Officer At the Neuroendocrine Tumor Research Foundation (NETRF), we often hear a familiar story: symptoms that don’t
The NETRF Year in Research: 2025
Thank you for your generous support. Because of you, 2025 was a year of meaningful momentum in neuroendocrine cancer research. Through 50 active NETRF-funded projects
GLP-1 Drugs and Neuroendocrine Cancer: What a New Study Suggests
By Anna Greene, PhD, NETRF Chief Scientific Officer Drugs like Ozempic®, Wegovy®, and Mounjaro®, known as GLP-1 receptor agonists, are now widely used to treat
Looking Ahead: Hope, Discovery, and Momentum from the 2025 NETRF Research Symposium
By Anna Greene, PhD, NETRF Chief Scientific Officer Each year, the Margie & Robert E. Petersen NETRF Research Symposium brings together leading scientists, clinicians, and